MarketInOut Stock Screener Log In | Sign Up
 

Novartis AG ADR

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 06/08/2026 10:59
Novartis AG ADR stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization283,161 mln
Float1,812 mln
Earnings Date07/21/2026

EPS

6.97
Strong

P / E

21.11
Premium valuation

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.7
Likely reliable

1-Year Forecast

154
Fairly priced

Relative Strength

20 / 100
Significantly lagging

Business Description

Novartis AG is a Swiss-based global pharmaceutical company founded in 1996 and headquartered in Basel, with operations spanning multiple countries worldwide. The company researches, develops, and sells a broad range of medicines targeting serious health conditions, including heart disease, cancer, immune disorders, and neurological conditions. Its product portfolio includes well-known treatments such as Entresto for heart failure, Cosentyx for inflammatory diseases, Kisqali for certain cancers, and Zolgensma for spinal muscular atrophy, among many others.

Key Fundamentals

EPS6.97
P/E21.11
ROE32.33
RPS29.18
ROIC14.14
ROA12.51
Interest Cover14.15
EBITDA, mln22,400
EV / EBITDA14.68
EV / EBIT19.34
Revenue, mln56,578
EV / Revenue5.81

Financial Strength

Altman Z-Score3.52
Piotroski F-Score 5 / 9
Beneish M-Score-2.7
Price to Intrinsic Value1.66
1-Year Target Price154
Shiller PE Ratio22.49
Short Ratio3.23
Short % of Float0.23

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.06% 77 / 100   
1 Month 1.27% 66 / 100   
2 Months -10.04% 18 / 100   
6 Months 13.35% 72 / 100   
1 Year 27.44% 68 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us